201 related articles for article (PubMed ID: 28993705)
1. A vicious loop of fatty acid-binding protein 4 and DNA methyltransferase 1 promotes acute myeloid leukemia and acts as a therapeutic target.
Yan F; Shen N; Pang JX; Zhao N; Zhang YW; Bode AM; Al-Kali A; Litzow MR; Li B; Liu SJ
Leukemia; 2018 Apr; 32(4):865-873. PubMed ID: 28993705
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid-binding protein FABP4 mechanistically links obesity with aggressive AML by enhancing aberrant DNA methylation in AML cells.
Yan F; Shen N; Pang JX; Zhang YW; Rao EY; Bode AM; Al-Kali A; Zhang DE; Litzow MR; Li B; Liu SJ
Leukemia; 2017 Jun; 31(6):1434-1442. PubMed ID: 27885273
[TBL] [Abstract][Full Text] [Related]
3. Curcumin down-regulates DNA methyltransferase 1 and plays an anti-leukemic role in acute myeloid leukemia.
Yu J; Peng Y; Wu LC; Xie Z; Deng Y; Hughes T; He S; Mo X; Chiu M; Wang QE; He X; Liu S; Grever MR; Chan KK; Liu Z
PLoS One; 2013; 8(2):e55934. PubMed ID: 23457487
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of Receptor Tyrosine Kinases Reverts Aberrant DNA Methylation in Acute Myeloid Leukemia.
Shen N; Yan F; Pang J; Zhao N; Gangat N; Wu L; Bode AM; Al-Kali A; Litzow MR; Liu S
Clin Cancer Res; 2017 Oct; 23(20):6254-6266. PubMed ID: 28720666
[No Abstract] [Full Text] [Related]
5. Preliminary study on the role of miR‑148a and DNMT1 in the pathogenesis of acute myeloid leukemia.
Wang XX; Zhang H; Li Y
Mol Med Rep; 2019 Apr; 19(4):2943-2952. PubMed ID: 30720097
[TBL] [Abstract][Full Text] [Related]
6. MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia.
Tagde A; Rajabi H; Stroopinsky D; Gali R; Alam M; Bouillez A; Kharbanda S; Stone R; Avigan D; Kufe D
Oncotarget; 2016 Jun; 7(26):38974-38987. PubMed ID: 27259275
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1.
Garzon R; Liu S; Fabbri M; Liu Z; Heaphy CE; Callegari E; Schwind S; Pang J; Yu J; Muthusamy N; Havelange V; Volinia S; Blum W; Rush LJ; Perrotti D; Andreeff M; Bloomfield CD; Byrd JC; Chan K; Wu LC; Croce CM; Marcucci G
Blood; 2009 Jun; 113(25):6411-8. PubMed ID: 19211935
[TBL] [Abstract][Full Text] [Related]
8. A nucleolin-DNMT1 regulatory axis in acute myeloid leukemogenesis.
Shen N; Yan F; Pang J; Wu LC; Al-Kali A; Litzow MR; Liu S
Oncotarget; 2014 Jul; 5(14):5494-509. PubMed ID: 25015109
[TBL] [Abstract][Full Text] [Related]
9. DNA methyltransferase-1 in acute myeloid leukaemia: beyond the maintenance of DNA methylation.
Li M; Zhang D
Ann Med; 2022 Dec; 54(1):2011-2023. PubMed ID: 35838271
[TBL] [Abstract][Full Text] [Related]
10. Targeting DNA hypermethylation: Computational modeling of DNA demethylation treatment of acute myeloid leukemia.
Przybilla J; Hopp L; Lübbert M; Loeffler M; Galle J
Epigenetics; 2017; 12(10):886-896. PubMed ID: 28758855
[TBL] [Abstract][Full Text] [Related]
11. Modulation of FABP4 hypomethylation by DNMT1 and its inverse interaction with miR-148a/152 in the placenta of preeclamptic rats and HTR-8 cells.
Yang A; Zhang H; Sun Y; Wang Y; Yang X; Yang X; Zhang H; Guo W; Zhu G; Tian J; Jia Y; Jiang Y
Placenta; 2016 Oct; 46():49-62. PubMed ID: 27697222
[TBL] [Abstract][Full Text] [Related]
12. DNA methyltransferase inhibition induces mouse embryonic stem cell differentiation into endothelial cells.
Banerjee S; Bacanamwo M
Exp Cell Res; 2010 Jan; 316(2):172-80. PubMed ID: 19715692
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic silencing of miR564 contributes to the leukemogenesis of t(8;21) acute myeloid leukemia.
Yang E; Guan W; Gong D; Gao X; Han C; Zhang J; Wang H; Wang M; Li Y; Yu L
Clin Sci (Lond); 2020 Dec; 134(23):3079-3091. PubMed ID: 33201243
[TBL] [Abstract][Full Text] [Related]
14. Targeting epigenetic pathway with gold nanoparticles for acute myeloid leukemia therapy.
Deng R; Shen N; Yang Y; Yu H; Xu S; Yang YW; Liu S; Meguellati K; Yan F
Biomaterials; 2018 Jun; 167():80-90. PubMed ID: 29554483
[TBL] [Abstract][Full Text] [Related]
15. Aberrant DNA methylation of mTOR pathway genes promotes inflammatory activation of immune cells in diabetic kidney disease.
Chen G; Chen H; Ren S; Xia M; Zhu J; Liu Y; Zhang L; Tang L; Sun L; Liu H; Dong Z
Kidney Int; 2019 Aug; 96(2):409-420. PubMed ID: 31101365
[TBL] [Abstract][Full Text] [Related]
16. Endothelial fatty liver binding protein 4: a new targetable mediator in hepatocellular carcinoma related to metabolic syndrome.
Laouirem S; Sannier A; Norkowski E; Cauchy F; Doblas S; Rautou PE; Albuquerque M; Garteiser P; Sognigbé L; Raffenne J; van Beers BE; Soubrane O; Bedossa P; Cros J; Paradis V
Oncogene; 2019 Apr; 38(16):3033-3046. PubMed ID: 30575815
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
Sengupta D; Deb M; Rath SK; Kar S; Parbin S; Pradhan N; Patra SK
Exp Cell Res; 2016 Aug; 346(2):176-87. PubMed ID: 27475839
[TBL] [Abstract][Full Text] [Related]
18. A regulatory circuit composed of DNA methyltransferases and receptor tyrosine kinases controls lung cancer cell aggressiveness.
Yan F; Shen N; Pang J; Zhao N; Deng B; Li B; Yang Y; Yang P; Molina JR; Liu S
Oncogene; 2017 Dec; 36(50):6919-6928. PubMed ID: 28869603
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of DNA methylation enhances differentiation of THP-1 cells and induces M1 polarization of differentiated macrophages.
Park J; Luo Y; Park JW; Kim SH; Hong YJ; Lim Y; Seo YJ; Bae J; Seo SB
Sci Rep; 2023 Aug; 13(1):13132. PubMed ID: 37573395
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic silencing of ZCCHC10 by the lncRNA SNHG1 promotes progression and venetoclax resistance of acute myeloid leukemia.
Zhou H; Zhang Q; Huang W; He C; Zhou C; Zhou J; Ning Y
Int J Oncol; 2023 May; 62(5):. PubMed ID: 37052262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
